October 2, 2019
Asahi Kasei Pharma said on October 1 that it has filed a complaint against Endo Ventures, seeking a preliminary injunction that would require the Dublin company to continue the supply of the Dupuytren’s contracture drug Xiaflex (collagenase clostridium histolyticum). The...read more